Developer docs
API playgroundTry for free, no card

Search company profiles

PulseOn

Full company profile

uuid000csop

Namestring
PulseOn
Legal namestring
PulseOn Oy
Websiteurl
pulseon.com
Company typeenum
Private
Founded yearint
2012
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersEspoo, Finland
HQ citystring
Espoo
HQ countrystring
Finland
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
arrhythmia detection devices, cardiac monitoring wearables, medical ECG devices, atrial fibrillation screening, remote patient monitoring
Industry3 codes
PRIMARYHLAHACAB
Cardiac Monitoring (ECG/Holter/Event/Patch, Loop Recorders)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLACAPAI
Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLAKABAC
Electrophysiology (Heart Rhythm)
NAICS code3 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing33451
  • Other Measuring and Controlling Device Manufacturing334519
SIC code2 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Measuring & Controlling Devices, Nec3829
Product category
Medical Wearable Cardiac Monitoring Devices
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Arrhythmia Monitor System (AMS-1)
TypeHardware Sales
Description

Sale of wrist-worn medical device system consisting of Arrhythmia Monitor (AM-1), Charging Dock (CD-1), optional Gateway (GW-1), and Data Management Service (DMS-1). The system is a CE-certified MDR Class IIa medical device for professional medical use.

pulseon.com
2Data Management Service (Cloud)
TypeManaged Services
Description

Secure cloud service with web interface for healthcare professionals, including automated arrhythmia classification and data storage. Sold as part of the complete arrhythmia monitoring solution.

next.pulseon.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure, Supply Chain
Pricing details1 tier
1Complete arrhythmia monitoring system for healthcare providers
ModelOtherBilling cadenceMulti-year contract
Notes

Quote-based pricing for healthcare institutions. System includes wrist device, charging dock, optional gateway, and cloud data management service.

next.pulseon.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

PulseOn sells the Arrhythmia Monitor System (AMS-1), a CE-certified MDR Class IIa medical device system for healthcare providers. The system comprises a wrist-worn device (AM-1) with continuous PPG optical heart rate monitoring and on-demand ECG measurement, a charging dock (CD-1), an optional home gateway (GW-1) for remote data transfer, and a cloud-based Data Management Service (DMS-1) with automated arrhythmia classification for healthcare professionals.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 95.5% sensitivity and 99.2% specificity for AF detection in population over 50 years
+4 more records
Product overview1 text field

PulseOn offers the PulseOn Arrhythmia Monitor System (AMS-1), a complete medical device solution for professional arrhythmia detection and monitoring. The system comprises the Arrhythmia Monitor Wrist Device (AM-1) for continuous PPG-based heart rate monitoring and on-demand ECG measurements, the Charging Dock (CD-1) for device charging and PC data transfer, and the optional Gateway (GW-1) for real-time home data transfer. All device data flows to the Data Management Service (DMS-1), a cloud-based platform providing secure storage, automated arrhythmia classification, and a web interface for healthcare professionals to review pre-analyzed results for faster diagnosis. The system is designed and manufactured in Finland, CE certified under MDR Class IIa.

Product and service5 records
1PulseOn Arrhythmia Monitor System (AMS-1)
CategoryCardiac monitoring system
Description

Complete arrhythmia monitoring system combining a CE-certified wrist-worn device with continuous PPG optical heart rate monitoring and instant ECG measurement capability, paired with a cloud-based Data Management Service for healthcare professionals to screen, detect, and monitor atrial fibrillation and other cardiac arrhythmias.

2PulseOn Arrhythmia Monitor Wrist Device (AM-1)
CategoryWearable medical device
Description

Wrist-worn medical device that continuously measures heartbeats via optical PPG sensors during periods of no motion, detects cardiac rhythm irregularities, and allows patients to take instant 35-second ECG recordings by placing their other hand on the device.

3PulseOn Charging Dock (CD-1)
CategoryDevice accessory
Description

Charging dock for recharging the wrist device in under 2 hours; also enables data connection with a computer to transfer results and configure the device for individual patients.

4PulseOn Gateway (GW-1)
CategoryDevice accessory
Description

Optional home device enabling easy data transfer from the wrist device to the Data Management Service, allowing nearly real-time remote monitoring of patients from a distance as an alternative to manual data syncing.

5PulseOn Data Management Service (DMS-1)
CategoryCloud software service
Description

Secure cloud-based service with an easy web interface for healthcare professionals providing storage, automated arrhythmia classification, and practical tools for interpreting results to enable faster diagnosis and treatment decisions. Available in Europe, UK, Middle East, Singapore, and Australia.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Clinical collaboration for validation studies and research on PulseOn arrhythmia detection technology. Joint research projects including published clinical trial article in Frontiers in Cardiovascular Medicine (2023). The collaboration validated the wrist-worn PPG+ECG solution for atrial fibrillation detection in ambulatory settings.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Withings ScanWatch and Move ECG combine wrist-worn optical heart rate with single-lead ECG for AF detection, overlapping PulseOn's PPG+ECG wrist device proposition in consumer and prosumer channels.

TypeEmerging player
Description

HeartBeam is an early-stage competitor building a credit-card-sized 3-lead ECG for ambulatory rhythm assessment, pursuing a similar clinical-grade remote cardiac monitoring opportunity with comparable regulatory strategy.

TypeBroad incumbent
Description

Apple Watch's FDA-cleared ECG feature represents a broad incumbent in consumer heart rhythm monitoring, raising consumer awareness of AF detection and shaping clinician expectations that PulseOn's clinical-grade device must surpass.

TypeDirect peer
Description

iRhythm's Zio long-term continuous ECG patch is the leading direct competitor in ambulatory arrhythmia detection, selling to the same cardiology and hospital customers with a similar clinical value proposition of replacing short-duration Holter monitoring.

TypeDirect peer
Description

AliveCor's KardiaMobile single-lead ECG device targets AF detection with similar sensitivity/specificity claims, addressing overlapping clinicians and patient populations through a hardware-plus-cloud subscription model.

TypeBroad incumbent
Description

Philips BioTel is a broad incumbent in cardiac diagnostics and remote monitoring with mobile cardiac telemetry and Holter offerings, competing head-to-head with PulseOn for hospital and cardiology contracts as part of a much larger portfolio.

TypeBroad incumbent
Description

Boston Scientific acquired Preventice BodyGuardian, a major ambulatory ECG monitoring service operating the same hospital channel as PulseOn with materially larger scale and clinical integration.

TypeEmerging player
Description

Peerbridge's Peerbridge ECG is a multi-lead wearable patch for continuous ambulatory rhythm monitoring, addressing the same Holter-replacement opportunity as PulseOn with a different form factor.

TypeDirect peer
Description

FibriCheck delivers PPG-based AF detection through smartphone cameras with regulatory clearances and hospital partnerships across Europe, directly overlapping PulseOn's remote arrhythmia screening use case and target buyers.

TypeEmerging player
Description

HeartcoR focuses on cloud-based cardiac arrhythmia analytics and remote monitoring services that can complement or compete with PulseOn's Data Management Service for hospitals seeking outsourced rhythm reporting.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses3 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles12 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

PulseOn

Medical Wearable Cardiac Monitoring Devicespulseon.com

PulseOn firmographics

Firmographics
Name
PulseOn
Legal name
PulseOn Oy
Website
https://pulseon.com
Company type
Private
Founded year
2012
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

PulseOn industry classification

Industry
Product category
Medical Wearable Cardiac Monitoring Devices
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451), Other Measuring and Controlling Device Manufacturing (334519)
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Measuring & Controlling Devices, Nec (3829)
akta.pro industry
PRIMARYHLAHACAB
Cardiac Monitoring (ECG/Holter/Event/Patch, Loop Recorders)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLACAPAI
Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLAKABAC
Electrophysiology (Heart Rhythm)

Keywords

  • Arrhythmia detection devices
  • Cardiac monitoring wearables
  • Medical ECG devices
  • Atrial fibrillation screening
  • Remote patient monitoring

Where PulseOn is headquartered

Location

Headquarters

HQ city
Espoo
HQ country
Finland
HQ region
Europe

Offices1 record

Markets served

PulseOn business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

  1. Arrhythmia Monitor System (AMS-1): Sale of wrist-worn medical device system consisting of Arrhythmia Monitor (AM-1), Charging Dock (CD-1), optional Gateway (GW-1), and Data Management Service (DMS-1). The system is a CE-certified MDR Class IIa medical device for professional medical use.
  2. Data Management Service (Cloud): Secure cloud service with web interface for healthcare professionals, including automated arrhythmia classification and data storage. Sold as part of the complete arrhythmia monitoring solution.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractComplete arrhythmia monitoring system for healthcare providers

Go-to-market motion2 records

Distribution channels1 record

Marketing channels4 records

PulseOn product offering

Product offering

Core offering

PulseOn sells the Arrhythmia Monitor System (AMS-1), a CE-certified MDR Class IIa medical device system for healthcare providers. The system comprises a wrist-worn device (AM-1) with continuous PPG optical heart rate monitoring and on-demand ECG measurement, a charging dock (CD-1), an optional home gateway (GW-1) for remote data transfer, and a cloud-based Data Management Service (DMS-1) with automated arrhythmia classification for healthcare professionals.

Product overview

PulseOn offers the PulseOn Arrhythmia Monitor System (AMS-1), a complete medical device solution for professional arrhythmia detection and monitoring. The system comprises the Arrhythmia Monitor Wrist Device (AM-1) for continuous PPG-based heart rate monitoring and on-demand ECG measurements, the Charging Dock (CD-1) for device charging and PC data transfer, and the optional Gateway (GW-1) for real-time home data transfer. All device data flows to the Data Management Service (DMS-1), a cloud-based platform providing secure storage, automated arrhythmia classification, and a web interface for healthcare professionals to review pre-analyzed results for faster diagnosis. The system is designed and manufactured in Finland, CE certified under MDR Class IIa.

Differentiator

Problem solved

Functional benefit

Products and services

  • PulseOn Arrhythmia Monitor System (AMS-1) Complete arrhythmia monitoring system combining a CE-certified wrist-worn device with continuous PPG optical heart rate monitoring and instant ECG measurement capability, paired with a cloud-based Data Management Service for healthcare professionals to screen, detect, and monitor atrial fibrillation and other cardiac arrhythmias.
  • PulseOn Arrhythmia Monitor Wrist Device (AM-1) Wrist-worn medical device that continuously measures heartbeats via optical PPG sensors during periods of no motion, detects cardiac rhythm irregularities, and allows patients to take instant 35-second ECG recordings by placing their other hand on the device.
  • PulseOn Charging Dock (CD-1) Charging dock for recharging the wrist device in under 2 hours; also enables data connection with a computer to transfer results and configure the device for individual patients.
  • PulseOn Gateway (GW-1) Optional home device enabling easy data transfer from the wrist device to the Data Management Service, allowing nearly real-time remote monitoring of patients from a distance as an alternative to manual data syncing.
  • PulseOn Data Management Service (DMS-1) Secure cloud-based service with an easy web interface for healthcare professionals providing storage, automated arrhythmia classification, and practical tools for interpreting results to enable faster diagnosis and treatment decisions. Available in Europe, UK, Middle East, Singapore, and Australia.

Quantifiable outcome

  • 95.5% sensitivity and 99.2% specificity for AF detection in population over 50 years
  • +4 more outcomes

Companies that use PulseOn

Customer profile

Named customers2 records

Segments2 records

Ideal customer profiles1 record

PulseOn technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature4 records

PulseOn partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Tampere Heart Hospital and Tampere UniversitycoreStrategic or Co-development PartnerClinical collaboration for validation studies and research on PulseOn arrhythmia detection technology. Joint research projects including published clinical trial article in Frontiers in Cardiovascular Medicine (2023). The collaboration validated the wrist-worn PPG+ECG solution for atrial fibrillation detection in ambulatory settings.

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

PulseOn competitors and assessment

Company assessment

Direct peers

  • Withings: Withings ScanWatch and Move ECG combine wrist-worn optical heart rate with single-lead ECG for AF detection, overlapping PulseOn's PPG+ECG wrist device proposition in consumer and prosumer channels.
  • iRhythm Technologies: iRhythm's Zio long-term continuous ECG patch is the leading direct competitor in ambulatory arrhythmia detection, selling to the same cardiology and hospital customers with a similar clinical value proposition of replacing short-duration Holter monitoring.
  • AliveCor: AliveCor's KardiaMobile single-lead ECG device targets AF detection with similar sensitivity/specificity claims, addressing overlapping clinicians and patient populations through a hardware-plus-cloud subscription model.
  • Qompium (FibriCheck): FibriCheck delivers PPG-based AF detection through smartphone cameras with regulatory clearances and hospital partnerships across Europe, directly overlapping PulseOn's remote arrhythmia screening use case and target buyers.

Emerging players

  • HeartBeam: HeartBeam is an early-stage competitor building a credit-card-sized 3-lead ECG for ambulatory rhythm assessment, pursuing a similar clinical-grade remote cardiac monitoring opportunity with comparable regulatory strategy.
  • Peerbridge Health: Peerbridge's Peerbridge ECG is a multi-lead wearable patch for continuous ambulatory rhythm monitoring, addressing the same Holter-replacement opportunity as PulseOn with a different form factor.
  • HeartcoR Solutions: HeartcoR focuses on cloud-based cardiac arrhythmia analytics and remote monitoring services that can complement or compete with PulseOn's Data Management Service for hospitals seeking outsourced rhythm reporting.

Broad incumbents

  • Apple (Apple Watch ECG): Apple Watch's FDA-cleared ECG feature represents a broad incumbent in consumer heart rhythm monitoring, raising consumer awareness of AF detection and shaping clinician expectations that PulseOn's clinical-grade device must surpass.
  • Philips (BioTel): Philips BioTel is a broad incumbent in cardiac diagnostics and remote monitoring with mobile cardiac telemetry and Holter offerings, competing head-to-head with PulseOn for hospital and cardiology contracts as part of a much larger portfolio.
  • Boston Scientific (Preventice Solutions): Boston Scientific acquired Preventice BodyGuardian, a major ambulatory ECG monitoring service operating the same hospital channel as PulseOn with materially larger scale and clinical integration.

Market position

Strengths5 records

Weaknesses3 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

PulseOn social profiles

Digital presence

PulseOn compliance and trust

Trust signal

Compliance3 records

PulseOn financial estimates

Financial estimate

Revenue estimate

Valuation estimate

PulseOn leadership team

Management profile

Number of profiles

Profiles12 records

PulseOn funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

PulseOn M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PulseOn

What does PulseOn do?

PulseOn sells the Arrhythmia Monitor System (AMS-1), a CE-certified MDR Class IIa medical device system for healthcare providers. The system comprises a wrist-worn device (AM-1) with continuous PPG optical heart rate monitoring and on-demand ECG measurement, a charging dock (CD-1), an optional home gateway (GW-1) for remote data transfer, and a cloud-based Data Management Service (DMS-1) with automated arrhythmia classification for healthcare professionals.

Is PulseOn a public or private company?

PulseOn is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was PulseOn founded?

PulseOn was founded in 2012. It employs 11 to 50 people.

Where is PulseOn based?

PulseOn is headquartered in Espoo, Finland, in the Europe region.

How does PulseOn make money?

Two revenue lines are on record. Arrhythmia Monitor System (AMS-1) is the primary driver. The others are data Management Service (Cloud).

Who are PulseOn's main competitors?

Direct peers on record are Withings, iRhythm Technologies, AliveCor and Qompium (FibriCheck). Emerging players are HeartBeam, Peerbridge Health and HeartcoR Solutions. Broad incumbents are Apple (Apple Watch ECG), Philips (BioTel) and Boston Scientific (Preventice Solutions).

Does PulseOn have an API?

No public API is recorded for PulseOn.

What industry is PulseOn in?

PulseOn's product category is Medical Wearable Cardiac Monitoring Devices. Its primary akta.pro industry code is HLAHACAB, Cardiac Monitoring (ECG/Holter/Event/Patch, Loop Recorders), with a secondary code of HLACAPAI, Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
ForbesWhen Counting Calories, You Can't Depend On That Fitness Tracker On Your WristStanford researchers tested seven wrist-worn fitness trackers with 60 volunteers, finding heart rate readings accurate but energy expenditure estimates off by an average of 27% to 93%. The Fitbit Surge had the lowest error margin, while the PulseOn was off by 93%, with higher errors for men, higher BMI, darker skin tone and walking. The study, published Wednesday in the Journal of Personalized Medicine, is now testing devices in real-world settings.FortuneCalorie Counting: Why You Shouldn't Do ItStanford researchers tested seven fitness trackers and found Fitbit had a 27% median error rate, while PulseOn had 93%. The study suggests calorie counting is unreliable, recommending a diet rich in whole foods and more movement instead.Las Vegas Review-JournalStudy questions fitness tracker accuracy when counting caloriesStanford researchers tested fitness trackers and found calorie-counting numbers often markedly incorrect, with PulseOn off by 93% and Fitbit Surge by 27%. The study suggests devices sabotage weight-loss efforts, as users may overestimate burned calories and eat more.The Commercial AppealYour fitness tracker could be way way offStanford researchers tested seven fitness trackers against medical-grade measurements and found most inaccurate for tracking energy expenditure. The best devices, Apple Watch and Fitbit, were off by about 20% on average, while PulseOn was off by 93%. The authors say the devices can be useful guidelines but not exact measurements.Wearable TechnologiesWearable Technologies Conference 2016 USA in San Francisco on July 12-13The Wearable Technologies Conference 2016 USA in San Francisco on July 12-13 features exhibitors like Rithmio, PulseOn, and Firstbeat showcasing wearable devices and analytics. Products include heart rate monitors, concussion detection, and smart helmets, with new innovations announced.GlobeNewswireST Chips Capture the Beat in the Market's Smallest Wearable Heart Monitor from PulseOnSTMicroelectronics' MEMS accelerometer and STM32L microcontroller enabled PulseOn's wrist-worn heart-rate monitor, which measures continuous heart rate without a chest strap. The device achieves ECG-level accuracy by tracking hand motion to eliminate noise, and is available for order.EngadgetTwo weeks with PulseOn's heart-rate monitoring wearable - EngadgetPulseOn, a spinout of Nokia, launched its first heart-rate monitoring wearable, the PulseOn, accepting pre-orders via Indiegogo. The $170 device uses optical sensors and requires a phone for full functionality, with a microUSB bulldog clip charger and opaque button controls. It is positioned as a run-tracking accessory rather than a casual watch.Business InsiderPulseOn, A Wearable Tech Startup Spun Out Of Nokia, Says It Has The Most Accurate Heart Monitor In The WorldPulseOn, a Finnish wearable startup spun out of Nokia, claims its wrist-worn heart-rate monitor is the most accurate. It raised €1 million to finalize production and enter markets in the first half of next year. The wearable tech market is projected to grow from $3-5 billion to $30-50 billion in two to three years.FinSMEsPulseOn Closes €1M Seed FundingPulseOn, a Finnish mobile wellness company, closed €1M seed funding from backers including Otar Margania and Olli Pohjanvirta. The funds will finalize its optical heart rate monitor and support market entry in the first half of 2014. The Nokia spin-off has 13 employees and develops a wrist device for sports and 24/7 use.